Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT0BI4Q)

DTT Name	Epstein-Barr virus Latent membrane protein 1 (EBV LMP1) DTT Info
Gene Name	EBV LMP1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LMP1-CAR-T cells	DMYGNDI	Nasopharyngeal carcinoma	2B6B	Phase 1/2	[1]
LMP-1/LMP-2 CTLs	DMZU2G1	Lymphoma	2A80-2A86	Phase 1	[2]
------------------------------------------------------------------------------------

1 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Ad5f35-LMPd1-2-transduced autologous dendritic cells	DMQW612	Nasopharyngeal carcinoma	2B6B	Investigative	[3]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	ClinicalTrials.gov (NCT02980315) A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
2	In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leuk Lymphoma. 2006 May;47(5):837-42.
3	CA patent application no. 876139, Nanotherapeutics for drug targeting.